Target intelligence / Profile preview

Matrix metalloproteinases (MMPs)

Target
MMPs
Molecular classification
Enzyme, Protease, Metalloprotease
01

Overview

Matrix metalloproteinases (MMPs) are a large family of zinc-dependent endopeptidases responsible for the degradation and remodeling of all components of the extracellular matrix (ECM). They play essential roles in normal physiological processes such as embryonic development, wound repair, and tissue morphogenesis by modulating the cellular microenvironment and releasing sequestered growth factors. In pathological states, dysregulated MMP activity is a hallmark of cancer progression, facilitating tumor invasion and metastasis by breaking down basement membranes and promoting angiogenesis. They are also heavily implicated in chronic inflammatory diseases, cardiovascular remodeling, and neurodegenerative disorders. While numerous small-molecule inhibitors were developed to target MMPs for cancer therapy, most failed in clinical trials due to poor selectivity and musculoskeletal toxicity, leading to a shift toward developing highly specific antibodies and allosteric inhibitors.

Other names
MatrixinsMatrix metallopeptidasesMMP familyExtracellular matrix-degrading enzymes
02

Mechanism of action

Inhibition of the zinc-dependent catalytic domain to prevent proteolytic cleavage of extracellular matrix substrates and signaling molecules.

03

Biological functions

Extracellular matrix remodelingTissue morphogenesisWound healingAngiogenesisCell migrationCleavage of cell surface receptorsActivation of growth factorsApoptosis regulation
04

Disease associations

Cancer (metastasis and invasion)Rheumatoid arthritisOsteoarthritisCardiovascular disease (atherosclerosis, aneurysm)Chronic obstructive pulmonary disease (COPD)PeriodontitisNeurodegenerative diseaseFibrosis
05

Safety considerations

Musculoskeletal syndrome (MSS)Joint pain and stiffnessLack of specificity leading to off-target effects on beneficial MMPsSystemic toxicity in early-generation broad-spectrum inhibitors
06

Interacting drugs

Marimastat

7 more in the full profile.

07

Biomarkers

MMP-9 serum levels (inflammation/cancer)MMP-2 expression (tumor metastasis)TIMP-1/MMP ratioUrinary MMPs (bladder cancer monitoring)

Beyond the preview

Go deeper on Matrix metalloproteinases (MMPs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matrix metalloproteinases (MMPs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call